Aptar CSP Technologies‘ Activ-Film Technology protects new at-home prescription and OTC Covid-19 tests

 

Aptar CSP Technologies (Crystal Lake, Illinois), a leader in material science and active packaging solutions (part of AptarGroup, Inc.), recently announced its Activ-Film technology was selected to protect two new at-home COVID-19 tests that recently received emergency use authorisation (EUA) from the U.S. Food and Drug Administration (FDA).

The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC (over the counter) COVID-19 at-home testing options without the need to visit a doctor’s office.

Aptar CSP’s Activ-Film technology is integrated into the dipstick of the diagnostic kits to protect against moisture and other environmental conditions that could otherwise impact test accuracy. Activ-Film leverages the company’s proprietary 3-Phase Activ-Polymer platform technology, which provides a broad spectrum of customised and highly-engineered solutions in a variety of configurations, such as Activ-Vial for housing diagnostics strips and dipsticks, and Activ-Tab, which is integrated within diagnostic cassettes. This material science-based active packaging technology currently protects a range of lateral flow, molecular, and electrochemical diagnostic test kits on the market today, including Quidel Corporation’s QuickVue Influenza and COVID-19 tests.

“As we continue to navigate through the COVID-19 crisis, this game-changing solution will help meet the urgent demand for COVID-19 testing in communities around the world,” said Badre Hammond, VP commercial operations, Aptar CSP Technologies. “We are committed to leveraging our material science expertise to enable our partners to meet the ongoing need for innovative healthcare solutions that help improve and save lives. This is another example of the value we bring to the market when sensitive diagnostic elements need protection.”

More information about the new at-home COVID-19 tests is available on the FDA website.

Caption: Covid-19 tests can highly profit from active and intelligent packaging solutions such as Aptar CSP Technologies’ Activ-Film Technology (photo: @Shutter_Speed – pixabay.com)